The decreased level of melatonin, the substance involved in the control of the sleep–wake cycle, has been reported among the patients with age‐related macular degeneration (AMD). However, knowledge about the… Click to show full abstract
The decreased level of melatonin, the substance involved in the control of the sleep–wake cycle, has been reported among the patients with age‐related macular degeneration (AMD). However, knowledge about the relationship between sleep disturbance and AMD is still limited. This longitudinal case–control study aims to investigate the risk of incident AMD among the patients with clinically diagnosed insomnia using the Taiwan National Health Insurance Research Database.
               
Click one of the above tabs to view related content.